(Q56093713)

1

0 references

Amlan Das

2

0 references

Muhammad Ashfaq

3

0 references

Angelika Wieck

Expert Opinion on Drug Metabolism & Toxicology

4

0 references

language of work or name

English

0 references

publication date

May 2009

0 references

published in

0 references

volume

5

0 references

issue

5

0 references

page(s)

539-551

0 references

cites work

Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Pharmacokinetic Drug Interactions with Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Status epilepticus associated with the combination of valproic acid and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Influence of co-medication on the metabolism of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Effects of a branched-chain amino acid drink in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Divalproex in the treatment of bipolar depression: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Prevention of postpartum episodes in women with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Developing the BALANCE trail--the role of the pilot study and start-up phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Valproate in the treatment of PTSD: systematic review and meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Divalproex loading in the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Use and safety profile of antiepileptic drugs in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Hematologic toxicity of sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Valproate-induced thrombocytopenia: a prospective monotherapy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Weight change with atypical antipsychotics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Fasting serum insulin and lipid levels in men with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Reproductive function and risk for PCOS in women treated for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Valproic acid toxicity: overview and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Birth defects after prenatal exposure to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Folic acid: a public-health challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

The longer term outcome of children born to mothers with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

A survey of antiepileptic prescribing to women of childbearing potential in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Safety of anticonvulsants in hepatic porphyrias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Adverse effects of atypical antipsychotics : differential risk and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Divalproex in the Treatment of Alcohol Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250902911455

Anticonvulsants for cocaine dependence

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD006754.PUB2